- $23.61m
- $7.46m
- $52.55m
- 55
- 59
- 24
- 43
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 40.4 | 42 | 48.3 | 45.6 | 52.5 |
Cost of Revenue | |||||
Gross Profit | 21.6 | 25.4 | 27.7 | 21.3 | 29.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 49.7 | 57.2 | 72.4 | 91.6 | 75.4 |
Operating Profit | -9.3 | -15.2 | -24.1 | -46.1 | -22.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12 | -16.8 | -26.7 | -47.7 | -23.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12 | -16.7 | -26.9 | -47.4 | -23.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -12 | -16.7 | -26.9 | -47.4 | -23.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -30.3 | -16.7 | -26.9 | -47.4 | -23.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.41 | -1.32 | -1.68 | -2.56 | -1.4 |